The Moving Average Convergence Divergence (MACD) for KNSA turned positive on October 27, 2026. Looking at past instances where KNSA's MACD turned positive, the stock continued to rise in 38 of 42 cases over the following month. The odds of a continued upward trend are 90%.
The Momentum Indicator moved above the 0 level on October 27, 2026. You may want to consider a long position or call options on KNSA as a result. In 81 of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 85%.
KNSA moved above its 50-day moving average on October 27, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for KNSA crossed bullishly above the 50-day moving average on October 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 16 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Following a +9.37% 3-day Advance, the price is estimated to grow further. Considering data from situations where KNSA advanced for three days, in 231 of 305 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
The 10-day RSI Indicator for KNSA moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 47 similar instances where the indicator moved out of overbought territory. In 34 of the 47 cases, the stock moved lower in the following days. This puts the odds of a move lower at 72%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where KNSA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.
KNSA broke above its upper Bollinger Band on October 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for KNSA entered a downward trend on October 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Profit vs. Risk Rating rating for this company is 1 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. KNSA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 40 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 59 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 83 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (11.127) is normal, around the industry mean (8.179). P/E Ratio (88.009) is within average values for comparable stocks, (-0.806). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.202). Dividend Yield (0.000) settles around the average of (0.046) among similar stocks. P/S Ratio (7.564) is also within normal values, averaging (181.047).
The Stochastic Oscillator for PWS moved into oversold territory on November 03, 2026. Be on the watch for the price uptrend or consolidation in the future. At that time, consider buying the stock or exploring call options.
The Moving Average Convergence Divergence (MACD) for PWS just turned positive on October 28, 2026. Looking at past instances where PWS's MACD turned positive, the stock continued to rise in 21 of 36 cases over the following month. The odds of a continued upward trend are 58%.
Following a +1.03% 3-day Advance, the price is estimated to grow further. Considering data from situations where PWS advanced for three days, in 191 of 301 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.
The Momentum Indicator moved below the 0 level on October 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PWS as a result. In 63 of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 70%.
PWS broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for PWS entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
KNSA | ||
|---|---|---|
OUTLOOK RATING 1..100 | 42 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 83 Overvalued | |
PROFIT vs RISK RATING 1..100 | 1 | |
SMR RATING 1..100 | 59 | |
PRICE GROWTH RATING 1..100 | 35 | |
P/E GROWTH RATING 1..100 | 40 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| KNSA | PWS | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 72% | N/A |
| Stochastic ODDS (%) | 1 day ago 71% | 1 day ago 68% |
| Momentum ODDS (%) | 1 day ago 85% | 1 day ago 70% |
| MACD ODDS (%) | 1 day ago 90% | 1 day ago 58% |
| TrendWeek ODDS (%) | 1 day ago 78% | 1 day ago 68% |
| TrendMonth ODDS (%) | 1 day ago 80% | 1 day ago 66% |
| Advances ODDS (%) | 6 days ago 76% | about 1 month ago 63% |
| Declines ODDS (%) | 2 days ago 74% | N/A |
| BollingerBands ODDS (%) | 1 day ago 67% | 1 day ago 73% |
| Aroon ODDS (%) | 1 day ago 70% | 1 day ago 66% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
KNSA’s FA Score shows that 1 FA rating(s) are green while .
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
KNSA’s TA Score shows that 5 TA indicator(s) are bullish.
KNSA (@Pharmaceuticals: Generic) experienced а +4.59% price change this weekfor the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.23%. For the same industry, the average monthly price growth was -7.21%, and the average quarterly price growth was +2.47%.
KNSA is expected to report earnings on Mar 02, 2027.
A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.
A.I.dvisor indicates that over the last year, KNSA has been loosely correlated with COYA. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if KNSA jumps, then COYA could also see price increases.
| Ticker / NAME | Correlation To KNSA | 1D Price Change % | ||
|---|---|---|---|---|
| KNSA | 100% | +2.74% | ||
| COYA - KNSA | 42% Loosely correlated | -3.72% | ||
| ABVC - KNSA | 40% Loosely correlated | +0.51% | ||
| JBIO - KNSA | 37% Loosely correlated | +4.59% | ||
| AMRN - KNSA | 36% Loosely correlated | -0.66% | ||
| SNDX - KNSA | 35% Loosely correlated | +9.08% | ||
More | ||||
A.I.dvisor tells us that PWS and RNA have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PWS and RNA's prices will move in lockstep.
| Ticker / NAME | Correlation To PWS | 1D Price Change % | ||
|---|---|---|---|---|
| PWS | 100% | -0.30% | ||
| RNA - PWS | 22% Poorly correlated | +1.99% | ||
| KNSA - PWS | 20% Poorly correlated | +2.74% | ||
| IVZ - PWS | 16% Poorly correlated | +1.76% | ||
| IOT - PWS | 15% Poorly correlated | -1.89% | ||
| SCHW - PWS | 14% Poorly correlated | +0.64% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FNGO | 131.97 | 3.96 | +3.10% |
| MicroSectors FANG+ Index 2X Leveraged ETNs (FNGO) | |||
| GTND | 24.77 | 0.09 | +0.37% |
| Goaltender ETF (GTND) | |||
| NZAC | 45.55 | 0.12 | +0.26% |
| State Street SPDR MSCI ACWI Climate Paris Aligned ETF (NZAC) | |||
| JIRE | 81.33 | -0.39 | -0.48% |
| JPMorgan International Research Enhanced Equity ETF (JIRE) | |||
| UTWY | 40.53 | -0.26 | -0.63% |
| US Treasury 20 Year Bond ETF (UTWY) | |||